MERRIMACK PHARMACEUTICALS INC - FORM S-1/A - EX-23.1 - EX-23.1 CONSENT OF PRICEWATERHOUSECOOPERS LLP - January 13, 2012

Attached files

file filename
S-1/A - S-1/A - MERRIMACK PHARMACEUTICALS INCa2205086zs-1a.htm
EX-3.5 - EX-3.5 AMENDED AND RESTATED BYLAWS OF THE REGISTRANT - MERRIMACK PHARMACEUTICALS INCa2206053zex-3_5.htm
EX-1.1 - EX-1.1 UNDERWRITING AGREEMENT - MERRIMACK PHARMACEUTICALS INCa2206053zex-1_1.htm
EX-5.1 - EX-5.1 OPINION OF WILMER CUTLER PICKERING HALE AND DORR LLP - MERRIMACK PHARMACEUTICALS INCa2206053zex-5_1.htm
EX-3.3 - EX-3.3 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION - MERRIMACK PHARMACEUTICALS INCa2206053zex-3_3.htm
EX-10.3 - EX-10.3 2011 STOCK INCENTIVE PLAN - MERRIMACK PHARMACEUTICALS INCa2206053zex-10_3.htm
EX-10.4 - EX-10.4 FORM OF INCENTIVE STOCK OPTION AGREEMENT UNDER 2011 STOCK INCENTIVE PLAN - MERRIMACK PHARMACEUTICALS INCa2206053zex-10_4.htm
EX-10.5 - EX-10.5 FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT UNDER 2011 STOCK INCENTIVE PLAN - MERRIMACK PHARMACEUTICALS INCa2206053zex-10_5.htm
EX-10.26 - EX-10.26 EMPLOYMENT AGREEMENT - WILLIAM M. MCCLEMENTS - MERRIMACK PHARMACEUTICALS INCa2206053zex-10_26.htm
EX-3.4 - EX-3.4 RESTATED CERTIFICATE OF INCORPORATION OF THE REGISTRANT - MERRIMACK PHARMACEUTICALS INCa2206053zex-3_4.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the use in this Amendment No. 4 to the Registration Statement on Form S-1 of Merrimack Pharmaceuticals, Inc. of our report dated July 8, 2011 relating to the financial statements of Merrimack Pharmaceuticals, Inc. which appears in such Registration Statement.  We also consent to the reference to us under the heading “Experts” in such Registration Statement.

 

 

/s/  PricewaterhouseCoopers LLP

 

 

Boston, Massachusetts
January 13, 2012

 

1


MERRIMACK PHARMACEUTICALS INC Reports